Results 151 to 160 of about 723,509 (268)

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Unmasking the intrinsic mechanistic limits of manganese Prussian blue analogues in aqueous Zn-ion batteries. [PDF]

Chem Sci
Saha S, Shang Y, Ma R, Zheng X, Kumar P, Kundu D.   +5 more
europepmc   +1 more source

AOFT Field Structures of the TCV L–H Transition

We present a compact, data-driven visualisation of organisational dynamics during the TCV L–H transition using the Alpha–Omega Field Theory (AOFT). The effective organisational frequency f(t) = \frac{1}{2\pi}\sqrt{P_{\mathrm{heat}}(t)/W_{\mathrm{MHD}}(t)} is computed directly from experimental heating-power and stored-energy time series of a ...
openaire   +2 more sources

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Depinning of KPZ interfaces in fractional Brownian landscapes. [PDF]

Sci Rep
Valizadeh N, Najafi MN.
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Toward Sustainable Lithium Recovery: A Universal Hydrothermal Approach for Lithium Extraction. [PDF]

ACS Appl Mater Interfaces
Wang Z, Hou J, Meng Z, Fu J, Yao Z, Yang Z, Wang Y.   +6 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Pivotal influence of ligand field stabilization energy on the extraction order of divalent metal ions by acidic extractants.

React Chem Eng
Raiguel S, Binnemans K.
europepmc   +1 more source

Both brefeldin A and latrunculin B treatment induces cytoplasmic aggregation of plasma membrane-associated proteins in epidermal cells, but not in columella cells. [PDF]

Plant Signal Behav
Chen A, Wang Q, Sheng X.
europepmc   +1 more source